Italia markets closed

Bausch Health Companies Inc. (BHC)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
8,76-0,21 (-2,34%)
Alla chiusura: 04:00PM EDT
8,77 +0,01 (+0,11%)
Dopo ore: 07:54PM EDT

Bausch Health Companies Inc.

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
514 744 6792
https://www.bauschhealth.com

Settore/iHealthcare
SettoreDrug Manufacturers - Specialty & Generic
Impiegati a tempo pieno20.270

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Thomas J. AppioCEO & Director2,74MN/D1962
Mr. John S. BarresiSenior VP, Controller, Chief Accounting Officer & Interim CFO796,8kN/D1973
Ms. Seana CarsonExecutive VP & General Counsel872,65kN/D1973
Mr. Mirza DautbegovicSenior VP & COON/DN/DN/D
Mr. Josh CoyleSenior Vice President of Sales & SalixN/DN/DN/D
Ms. Kathleen FitzpatrickSenior VP & Chief HR OfficerN/DN/DN/D
Dr. Tage Ramakrishna M.D.Chief Medical Officer and President of R&DN/DN/D1974
Mr. Jeff HartnessExecutive VP of Market Access, Commercial Operations, Neurology, Generics & Government AffairsN/DN/DN/D
Dr. Graham JacksonSenior VP & Chief Quality OfficerN/DN/DN/D
Mr. Cees HeimanSenior Vice President of Europe & CanadaN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Governance aziendale

L'ISS Governance QualityScore di Bausch Health Companies Inc. al 1 aprile 2024 è 4. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 2; diritti degli azionisti: 3; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.